About The Study: In this study of patients enrolled in Medicare in 2022, those at the highest risk for severe COVID-19 infection received COVID-19 therapy less often than those with the least risk. Disparities in therapy access were found by patient age, race and ethnicity, Medicaid eligibility, and nursing home residence.
Authors: Michael L. Barnett, M.D., of the Harvard T.H. Chan School of Public Health in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2023.5044)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.5044?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=012624
About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
JAMA Health Forum